Literature DB >> 19778338

Core temperature changes in resuspended red blood cells (RBCs) and pediatric RBCs removed from refrigerated storage.

Holly Elizabeth Perry1, Priyanka Prasad, Susy Kirwan, Yuan Qing Huang.   

Abstract

BACKGROUND: The 30-minute rule, whereby intact red blood cell (RBC) products may be returned to stock if returned to 4 degrees C storage within 30 minutes of issue, was established many years ago. It was based on observations that the core temperature of units of whole blood removed from storage temperatures of 1 to 6 degrees C, and left at room temperature, would reach 10 degrees C at between 45 minutes and 1 hour. STUDY DESIGN AND METHODS: Forty-one units of RBCs resuspended leukoreduced and 8 units of pediatric RBCs resuspended leukoreduced were exposed to ambient temperature for periods of time between 0 and 60 minutes. Core temperatures of all units were measured at 1-minute or 5-minute intervals.
RESULTS: Resuspended RBCs units reached a mean core temperature of 10 degrees C at 15 minutes, 12.7 degrees C at 30 minutes, and 15 degrees C at 60 minutes. Pediatric RBCs reached a mean core temperature of 12.8 degrees C at 15 minutes, 15.5 degrees C at 30 minutes, and 17.8 degrees C at 60 minutes.
CONCLUSION: In view of our results, and the range of RBC products now available, it may be timely for blood services to review and reduce the 30-minute rule.

Mesh:

Year:  2009        PMID: 19778338     DOI: 10.1111/j.1537-2995.2009.02384.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Monitoring of Storage and Transportation Temperature Conditions in Red Blood Cell Units: A Cross-Sectional Study.

Authors:  Shokoufeh Aalaei; Shahram Amini; Mohammad Reza Keramati; Hadi Shahraki; Saeid Eslami
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-12       Impact factor: 0.900

2.  Thermometry of red blood cell concentrate: magnetic resonance decoding warm up process.

Authors:  Gert Reiter; Ursula Reiter; Thomas Wagner; Noemi Kozma; Jörg Roland; Helmut Schöllnast; Franz Ebner; Gerhard Lanzer
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.